magenta_spine_525

Globally, lower backs ache for treatment

MONASH U. (AUS) — Low back pain is the highest contributor to disability in the world, according to a new international study.

A study published by The Lancet in the latest Global Burden of Disease Study, found lower back pain and osteoarthritis are now ranked second only to cancer as a leading cause of disease burden in Australasia.

The findings confirmed the global burden of low back pain was much higher than previously estimated and re-allocation of resources for research, treatment, and prevention was urgently needed, says Professor Rachelle Buchbinder of Monash University’s department of epidemiology and preventive medicine and the Cabrini Institute.

“Our study shows that lower back pain and osteoarthritis are now ranked second only to cancer as the leading cause of disease burden in Australasia,” Buchbinder says.

“With aging populations, it is highly likely that this burden will increase, suggesting that the health and research priorities that governments and others give to low back pain should be increased.

“Research is urgently needed to develop effective prevention and treatment strategies with the potential benefits of public health interventions likely to be substantial.”

Extensive research from 47 countries found the global burden of disability due to low back pain was previously underestimated. The researchers identified 116 studies measuring the prevalence of lower back pain worldwide and found 780 estimates from 47 countries. They found the prevalence of low back pain was higher in women and peaked in adolescence and at age 65 years.

The study also found that in Australasia, musculoskeletal conditions account for 15 percent of the total burden of death and disability, just behind cancer at 16.2 percent followed by heart disease, mental health, and substance abuse at around 13 percent.

“These are all important health issues and recognized as national health priorities by the Australian government but to date musculoskeletal conditions has not received an equitable level of priority,” says Buchbinder, who led the study in collaboration with Professor Lyn March of the University of Sydney.

The Global Burden of Disease study, funded by the Bill and Melinda Gates Foundation, was conducted by a consortium of international experts including investigators from Johns Hopkins University, University of Queensland, Boston University, University of Melbourne, Emory University, University of Pennsylvania, Columbia University, Vanderbilt University, among others.

Source: Monash University

chat0 Comments

You are free to share this article under the Creative Commons Attribution-NoDerivs 3.0 Unported license.

0 Comments

We respect your privacy.